Sign in
4

Changes in Ownership

ARTIVION, INC. Filed Acc 0001628280-25-053859

SVP, Clinical & MD Affair sold 47,376 shares at an average $45.04 ($2,133,920)

  • SVP, Clinical & MD Affair acquired 47,376 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stanton Marshall S. SVP, Clinical & MD Affair 2025-11-21 Option exercise +20,301 $18.44 $374,350 65,054 D: show line 1 in the form
Stanton Marshall S. SVP, Clinical & MD Affair 2025-11-21 Sale −14,586 $44.92 $655,189 50,468 D: show line 2 in the form
Stanton Marshall S. SVP, Clinical & MD Affair 2025-11-21 Sale −5,715 $45.35 $259,152 44,753 D: show line 3 in the form
Stanton Marshall S. SVP, Clinical & MD Affair 2025-11-21 Option exercise +27,075 $11.03 $298,637 71,828 D: show line 4 in the form
Stanton Marshall S. SVP, Clinical & MD Affair 2025-11-21 Sale −18,705 $44.91 $840,042 53,123 D: show line 5 in the form
Stanton Marshall S. SVP, Clinical & MD Affair 2025-11-21 Sale −8,370 $45.35 $379,538 44,753 D: show line 6 in the form
Open-market sales · 47,376 sh · avg $45.04 · $2,133,920

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Stanton Marshall S. SVP, Clinical & MD Affair 2025-11-21 Option exercise · Stock Options (Right to buy) −20,301 0 D: show line 7 in the form
Stanton Marshall S. SVP, Clinical & MD Affair 2025-11-21 Option exercise · Stock Options (Right to buy) −27,075 0 D: show line 8 in the form
Loading xslF345X05/wk-form4_1764023022.xml…